{"url_path":"/sec/ormp/8-k/2026-06-30/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 ** **Amendments to Articles of Incorporation or Bylaws; Change in Fiscal","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-30","source_url":"https://www.sec.gov/Archives/edgar/data/1176309/0001213900-26-073709-index.html","accession_number":"0001213900-26-073709","cik":"0001176309","ticker":"ORMP","issuer_name":"ORAMED PHARMACEUTICALS INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1176309/0001213900-26-073709-index.html","primary_entity_key":"0001176309","primary_entity_name":"ORAMED PHARMACEUTICALS INC."},"word_count":228,"has_tables":true,"body_markdown":"**Item\n5.03** **Amendments to Articles of Incorporation or Bylaws; Change in Fiscal\nYear.**\n\n \n\nOn\nJune 28, 2026, the board of directors (the “Board”) of Oramed Pharmaceuticals Inc. (the “Company”) approved the\nFifth Amended and Restated Bylaws (the “Amended Bylaws”) of the Company, effective as of June 25, 2026. The Fifth Amended\nand Restated Bylaws amend and restate those certain Fourth Amended and Restated Bylaws of the Company, to (i) revise the record date procedures\nfor stockholder action by written consent by providing that, if the Board of does not fix a record date within the applicable period,\nthe record date will be fixed in accordance with Section 213(b) of the Delaware General Corporation Law, (ii) eliminate former Article\nIII, Section 11(b), which required a stockholder requesting a record date for action by written consent to provide, among other information,\ncertain information regarding the proposed action, related proposals and solicitation plans, and (iii) revise the effectiveness provision\nfor stockholder consents to provide that consents signed by a sufficient number of stockholders must be delivered to the Company in accordance\nwith applicable law within 60 days of the first date on which a consent is delivered to the Company.\n\n \n\nThe\nforegoing description of the Amended Bylaws is qualified by reference to the Amended Bylaws, a copy of which is attached hereto as Exhibit\n3.1 and is incorporated herein by reference."}